Kolexia
Bourhis Jean Radio-thérapie
Bourhis Jean
Radio-thérapie
Gustave-Roussy
Villejuif, France
332 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la tête et du cou Carcinomes Carcinome épidermoïde Carcinome épidermoïde de la tête et du cou Tumeurs du poumon Récidive tumorale locale Métastase tumorale Tumeurs de l'oropharynx Tumeurs du sein

Collaborateurs

Voir plus
Tao Yungan
Tao Yungan
Gustave-Roussy, Villejuif, France
Blanchard Pierre
Blanchard Pierre
Gustave-Roussy, Villejuif, France
Auperin Anne
Auperin Anne
Gustave-Roussy, Villejuif, France
Thariat Juliette
Thariat Juliette
Centre François-Baclesse, Caen, France

Industries

Voir plus
Merck-Serono
1 collaboration(s)
Dernière en 2022
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX): A Randomized, Double-Blind Placebo-Controlled, Phase 3 Study of Debio 1143 in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX)
Essai Clinique (Emd Serono)   18 mars 2024
Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trial.
The Lancet. Healthy longevity   05 mars 2024
Very high-energy electron therapy as light-particle alternative to transmission proton FLASH therapy - An evaluation of dosimetric performances.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology   18 février 2024
Randomized phase II selection trial of FLASH and conventional radiotherapy for patients with localized cutaneous squamous cell carcinoma or basal cell carcinoma: A study protocol.
Clinical and translational radiation oncology   08 février 2024
ELAN-UNFIT: Multicentric Randomized Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent and/or Metastatic Squamous Cell Head and Neck Cancer in Elderly Unfit Patients According to Geriatric Evaluation
Essai Clinique (Merck-Serono)   07 février 2024
Comparison of volumetric modulated arc therapy and helical tomotherapy for prostate cancer using Pareto fronts.
Medical physics   06 décembre 2023
VoiceS: Voice Quality After Transoral CO2-Laser Surgery Versus Single Vocal Cord Irradiation for Unilateral Stage 0 & I Glottic Larynx Cancer - A Randomized Phase III Trial
Essai Clinique (Olgun Elicin)   29 novembre 2023
Season of radiotherapy and outcomes of head & neck cancer patients in the MACH-NC & MARCH meta-analyses.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology   11 novembre 2023
Recurrences of ventricular tachycardia after stereotactic arrhythmia radioablation arise outside the treated volume: analysis of the Swiss cohort.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology   07 octobre 2023
853O OMITting frontline chemotherapy in head and neck cancer (HNSCC) patients with 1-3 oligometastases using stereotactic ablative radiotherapy (SABR), the GORTEC 2014-04 “OMET” randomized phase II trial
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023